CN1305491C - 一种治疗肠易激综合征的中药组合物及其制备方法 - Google Patents
一种治疗肠易激综合征的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN1305491C CN1305491C CNB200410039432XA CN200410039432A CN1305491C CN 1305491 C CN1305491 C CN 1305491C CN B200410039432X A CNB200410039432X A CN B200410039432XA CN 200410039432 A CN200410039432 A CN 200410039432A CN 1305491 C CN1305491 C CN 1305491C
- Authority
- CN
- China
- Prior art keywords
- weight portion
- irritable bowel
- bowel syndrome
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 208000002551 irritable bowel syndrome Diseases 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 claims abstract description 70
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000341 volatile oil Substances 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 10
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000001116 FEMA 4028 Substances 0.000 claims abstract description 6
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims abstract description 6
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims abstract description 6
- 229960004853 betadex Drugs 0.000 claims abstract description 6
- 241000208340 Araliaceae Species 0.000 claims description 34
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 34
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 34
- 235000008434 ginseng Nutrition 0.000 claims description 34
- 210000000582 semen Anatomy 0.000 claims description 28
- 239000002775 capsule Substances 0.000 claims description 27
- 241001534869 Terminalia Species 0.000 claims description 26
- 239000006187 pill Substances 0.000 claims description 23
- 229940023488 pill Drugs 0.000 claims description 22
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 16
- 239000006071 cream Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000004821 distillation Methods 0.000 claims description 6
- 210000000214 mouth Anatomy 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000007910 chewable tablet Substances 0.000 claims description 2
- 229940068682 chewable tablet Drugs 0.000 claims description 2
- 239000003405 delayed action preparation Substances 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000007938 effervescent tablet Substances 0.000 claims description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000006190 sub-lingual tablet Substances 0.000 claims description 2
- 229940098466 sublingual tablet Drugs 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 235000013372 meat Nutrition 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 abstract description 57
- 210000003405 ileum Anatomy 0.000 abstract description 20
- 238000002474 experimental method Methods 0.000 abstract description 18
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 abstract description 16
- 230000002401 inhibitory effect Effects 0.000 abstract description 16
- 230000033001 locomotion Effects 0.000 abstract description 14
- 241000283973 Oryctolagus cuniculus Species 0.000 abstract description 12
- 210000000813 small intestine Anatomy 0.000 abstract description 9
- 208000005392 Spasm Diseases 0.000 abstract description 8
- 229960001340 histamine Drugs 0.000 abstract description 8
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 abstract description 7
- 229960004373 acetylcholine Drugs 0.000 abstract description 7
- ALWKGYPQUAPLQC-UHFFFAOYSA-N neostigmine Chemical compound CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 ALWKGYPQUAPLQC-UHFFFAOYSA-N 0.000 abstract description 7
- 229960002362 neostigmine Drugs 0.000 abstract description 7
- 241000700199 Cavia porcellus Species 0.000 abstract description 6
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 abstract description 6
- 229910001626 barium chloride Inorganic materials 0.000 abstract description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract description 2
- 229930195725 Mannitol Natural products 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 239000000594 mannitol Substances 0.000 abstract description 2
- 235000010355 mannitol Nutrition 0.000 abstract description 2
- 235000015489 Emblica officinalis Nutrition 0.000 abstract 1
- 244000270834 Myristica fragrans Species 0.000 abstract 1
- 235000009421 Myristica fragrans Nutrition 0.000 abstract 1
- 235000002789 Panax ginseng Nutrition 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- 240000003152 Rhus chinensis Species 0.000 abstract 1
- 235000014220 Rhus chinensis Nutrition 0.000 abstract 1
- 244000277583 Terminalia catappa Species 0.000 abstract 1
- 235000011517 Terminalia chebula Nutrition 0.000 abstract 1
- 210000003056 antler Anatomy 0.000 abstract 1
- 229940045511 barium chloride Drugs 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 239000001702 nutmeg Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 238000010298 pulverizing process Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 46
- 230000000694 effects Effects 0.000 description 36
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 27
- 201000010099 disease Diseases 0.000 description 25
- 230000000968 intestinal effect Effects 0.000 description 25
- 229940079593 drug Drugs 0.000 description 18
- 241000699670 Mus sp. Species 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 210000002784 stomach Anatomy 0.000 description 16
- 210000000936 intestine Anatomy 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 230000001142 anti-diarrhea Effects 0.000 description 13
- 208000011580 syndromic disease Diseases 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 208000019902 chronic diarrheal disease Diseases 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 239000003610 charcoal Substances 0.000 description 9
- 208000001848 dysentery Diseases 0.000 description 9
- 230000037396 body weight Effects 0.000 description 8
- 230000013872 defecation Effects 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 8
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 230000002496 gastric effect Effects 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 238000010792 warming Methods 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 229960000583 acetic acid Drugs 0.000 description 6
- 230000008485 antagonism Effects 0.000 description 6
- 239000012362 glacial acetic acid Substances 0.000 description 6
- 238000001802 infusion Methods 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 241000700198 Cavia Species 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 208000031975 Yang Deficiency Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 229940095970 imodium Drugs 0.000 description 5
- 210000002429 large intestine Anatomy 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- 208000014540 Functional gastrointestinal disease Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 208000019790 abdominal distention Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 201000007637 bowel dysfunction Diseases 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 230000003871 intestinal function Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 3
- 241000244186 Ascaris Species 0.000 description 3
- 241000756943 Codonopsis Species 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 3
- 239000001263 FEMA 3042 Substances 0.000 description 3
- 206010021143 Hypoxia Diseases 0.000 description 3
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 3
- 230000002180 anti-stress Effects 0.000 description 3
- 239000003212 astringent agent Substances 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 230000000741 diarrhetic effect Effects 0.000 description 3
- 229940000406 drug candidate Drugs 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000001809 melena Anatomy 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 230000000306 recurrent effect Effects 0.000 description 3
- 235000015523 tannic acid Nutrition 0.000 description 3
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 3
- 229940033123 tannic acid Drugs 0.000 description 3
- 229920002258 tannic acid Polymers 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 208000002881 Colic Diseases 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 206010028140 Mucous stools Diseases 0.000 description 2
- 208000008238 Muscle Spasticity Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000003777 experimental drug Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000008991 intestinal motility Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 229940032171 plum preparation Drugs 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 208000018198 spasticity Diseases 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
- 229930008281 A03AD01 - Papaverine Natural products 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 201000002045 Ancylostomiasis Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 208000033211 Ankylostomiasis Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 241000758794 Asarum Species 0.000 description 1
- 229910000014 Bismuth subcarbonate Inorganic materials 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008616 Cholecystitis and cholelithiasis Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 208000034347 Faecal incontinence Diseases 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 206010020376 Hookworm infection Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000498779 Myristica Species 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 244000131415 Zanthoxylum piperitum Species 0.000 description 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- ILGIZSNSMBCLIT-UHFFFAOYSA-M [Cl-].[Ba].CC(=O)OCC[N+](C)(C)C Chemical compound [Cl-].[Ba].CC(=O)OCC[N+](C)(C)C ILGIZSNSMBCLIT-UHFFFAOYSA-M 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- MGLUJXPJRXTKJM-UHFFFAOYSA-L bismuth subcarbonate Chemical compound O=[Bi]OC(=O)O[Bi]=O MGLUJXPJRXTKJM-UHFFFAOYSA-L 0.000 description 1
- 229940036358 bismuth subcarbonate Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 229960001789 papaverine Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 208000037922 refractory disease Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 230000001843 schistosomicidal effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 210000001599 sigmoid colon Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- -1 tannalbin Chemical compound 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
动物数 | 剂量 | 小肠长度(cm) | 炭末推进距离(cm) | 推进率(%)(x±s) | P值 | |
空白对照组易蒙停组补脾益肠丸组本发明胶囊组本发明胶囊组 | 1010101010 | 盐水2mg/kg6.0g/kg2.0g/kg1.0g/kg | 42.1±3.342.5±2.842.5±2.242.8±2.543.5±2.7 | 22.4±2.718.2±4.420.3±2.917.0±3.320.0±2.8 | 53.2±5.143.0±10.5*47.6±6.0*39.8±7.9*△46.3±8.3* | <0.05<0.05<0.01<0.05<0.05 |
动物数 | 剂量 | 小肠总长(cm) | 炭末推进距离(cm) | 推进率(%)(x±s) | P值 | |
新斯的明组易蒙停组 | 1010 | 盐水2mg/kg | 42.2±1.845.0±4.6 | 27.7±4.920.3±3.7 | 65.6±11.445.7±11.3* | <0.05 |
补脾益肠丸组本发明组本发明组 | 101010 | 6.0g/kg2.0g/kg1.0g/kg | 44.2±3.344.9±4.742.8±3.8 | 24.2±3.121.0±2.823.8±3.9 | 54.8±6.8*46.8±4.9*△55.6±8.2* | <0.05<0.01<0.01<0.05 |
剂量(g/kg) | 收缩频率(次/min) | 收缩幅度(cm) | |||
给药前 | 给药后 | 给约前 | 给药后 | ||
生理盐水本发明胶囊 | 等容积2.0 | 12.4±1.512.8±2.3 | 13.8±2.7*5.8±4.6**△ | 1.7±0.31.8±0.3 | 1.6±0.3*0.6±0.3**△ |
剂量 | 肠段数 | 自律收缩松驰幅度(mm) | 拮抗百分率(%) | ||
乙酰胆碱 | 氯化钡 | 组织胺 | |||
25%-0.4ml50%-0.4ml100%-0.4ml | 101010 | 3.2±0.55.8±1.210.2±2.2 | 44.4±14.865.2±19.787.1±13.2 | 39.7±18.560.8±17.879.2±23.4 | 53.6±16.670.5±17.092.7±9.6 |
动物数 | 剂量 | 排出黑粪时间(min) | 黑粪点数(个/6h) | P值 | |
模型对照组易蒙停组补脾益肠丸组本发明组本发明组 | 1010101010 | 盐水2mg/kg6.0g/kg2.0g/kg1.0g/kg | 72.5±l9.9140.8±39.9*78.7±21.9125.7±25.9*△119.5±29.9* | 23.3±7.610.9±4.8*17.2±6.6*11.9±3.5*△16.5±6.4* | <0.01<0.01<0.01<0.05<0.05 |
动物数 | 剂量 | 扭体次数 | P值 | |
空白对照组补脾益肠丸组本发明组本发明组 | 12151515 | 盐水6.0g/kg2.0g/kg1.0g/kg | 33.5±10.115.6±8.5*21.3±12.8*28.1±15.3 | <0.01<0.05 |
组别 | 例数 | 痊愈 | 显效 | 有效 | 无效 | 显愈率 | 有效率 |
中医证候疗效 | 118 | 39 | 41 | 29 | 9 | 67.80 | 92.37 |
钡条疗效 | 92 | 35 | 33 | 17 | 7 | 73.91 | 92.39 |
止痛疗效 | 112 | 86 | 16 | 10 | 76.79 | 91.07 | |
止泻疗效 | 115 | 80 | 24 | 11 | 69.57 | 90.43 |
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410039432XA CN1305491C (zh) | 2004-02-12 | 2004-02-12 | 一种治疗肠易激综合征的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200410039432XA CN1305491C (zh) | 2004-02-12 | 2004-02-12 | 一种治疗肠易激综合征的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1654063A CN1654063A (zh) | 2005-08-17 |
CN1305491C true CN1305491C (zh) | 2007-03-21 |
Family
ID=34892345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200410039432XA Expired - Lifetime CN1305491C (zh) | 2004-02-12 | 2004-02-12 | 一种治疗肠易激综合征的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1305491C (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488767B (zh) * | 2011-12-27 | 2013-12-25 | 张朝晖 | 一种含有鬼针草治疗畜禽细菌性腹泻的复方组合物 |
CN103316115A (zh) * | 2013-07-12 | 2013-09-25 | 石强 | 一种中药组合物及其制备方法 |
CN110433208A (zh) * | 2019-08-15 | 2019-11-12 | 贵州联盛药业有限公司 | 参倍固肠胶囊倍他环糊精包合方法 |
CN110437926A (zh) * | 2019-08-16 | 2019-11-12 | 贵州联盛药业有限公司 | 参倍固肠胶囊中挥发油提取方法 |
CN113493796B (zh) * | 2020-03-18 | 2023-05-30 | 苏州优信合生技术有限公司 | 苯丙酮尿症治疗用益生菌工程菌株的构建方法与应用 |
-
2004
- 2004-02-12 CN CNB200410039432XA patent/CN1305491C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1654063A (zh) | 2005-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105878898A (zh) | 一种小儿健脾止泻散 | |
CN1297291C (zh) | 一种戒除毒瘾的药物及其制备方法 | |
CN102488847B (zh) | 治疗鸡传染性法氏囊病的中药组合物、制备方法和应用 | |
CN103749984A (zh) | 用于治疗鸡输卵管炎的饲料及其制备方法 | |
CN1824185A (zh) | 一种治疗失眠、功能性消化不良和便秘的中药组合物及其制备方法 | |
CN104107386A (zh) | 用于治疗小鹅瘟的药物组合物及其制备方法 | |
CN1305491C (zh) | 一种治疗肠易激综合征的中药组合物及其制备方法 | |
CN1511544A (zh) | 预防和治疗肠粘连的中药复方制剂及制备方法 | |
CN1541676A (zh) | 一种产后补血保健药物及其制备方法和应用 | |
CN103431260A (zh) | 供胃肠道吸收障碍、胰腺炎患者食用的五谷杂粮全营养配方食品 | |
CN1738633A (zh) | 来自药用植物的抗肥胖组分及其组合物 | |
CN105995091A (zh) | 一种治疗猪便秘的饲料添加剂及其制备方法 | |
CN1660387A (zh) | 调理人体内脏各器官机能平衡的保健制剂及其制备方法 | |
CN103933538A (zh) | 用于治疗脾肾阳虚型肝硬化腹水的药物及其制备方法 | |
CN103735832A (zh) | 用于治疗鸡输卵管炎的药物及其制备方法 | |
CN102824414A (zh) | 一种用于治疗便秘的药茶 | |
CN104056171B (zh) | 治疗小儿疳积的中药 | |
CN106266565A (zh) | 一种弓形虫病的药物及该药物的制备方法 | |
CN1465387A (zh) | 一种治疗食管癌的中药制剂 | |
KR101111711B1 (ko) | 복부비만의 개선 및 예방용 한약재를 이용한 드링크 액 제조방법 및 그에 의해 제조된 드링크 액 | |
CN1251751C (zh) | 一种治疗慢性肝病及抗肝纤维化的中药及其制备工艺 | |
CN100342901C (zh) | 一种用于治疗糖尿病的中药组合物、其制备方法及其用途 | |
CN1289139C (zh) | 一种治疗结肠炎症的药物及其制备方法 | |
CN103610991B (zh) | 用于治疗猪胃溃疡的药物及其制备方法 | |
CN103142882A (zh) | 一种治疗胃肠功能紊乱的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Chinese medicinal composite for treating intestinal irritable syndrome and its preparation method Effective date of registration: 20160927 Granted publication date: 20070321 Pledgee: Bank of Guiyang Limited by Share Ltd. Zunyi branch Pledgor: Guizhou Liansheng Pharmaceutical Co.,Ltd. Registration number: 2016990000821 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200721 Granted publication date: 20070321 Pledgee: Bank of Guiyang Limited by Share Ltd. Zunyi branch Pledgor: Guizhou Liansheng Pharmaceutical Co.,Ltd. Registration number: 2016990000821 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CX01 | Expiry of patent term |
Granted publication date: 20070321 |
|
CX01 | Expiry of patent term |